Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Latest Articles

  • The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human <em>β</em>1-Adrenoceptor
    Open Access
    The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human β1-Adrenoceptor
    Victor Jun Yu Lim, Richard G. W. Proudman, Stefania Monteleone, Peter Kolb and Jillian G. Baker
    Molecular Pharmacology February 2023, 103 (2) 89-99; DOI: https://doi.org/10.1124/molpharm.122.000583
  • Open Access
    Differences in Sustained Cellular Effects of MET inhibitors Are Driven by Prolonged Target Engagement and Lysosomal Retention
    Nina Berges, Jan Henrik Klug, Anna Eicher, Jennifer Loehr, Daniel Schwarz, Joerg Bomke, Birgitta Leuthner, Dominique Perrin and Oliver Schadt
    Molecular Pharmacology February 2023, 103 (2) 77-88; DOI: https://doi.org/10.1124/molpharm.122.000590
  • You have access
    Insights Into the Differential Desensitization of α4β2 Nicotinic Acetylcholine Receptor Isoforms Obtained With Positive Allosteric Modulation of Mutant Receptors
    Roger L. Papke and Clare Stokes
    Molecular Pharmacology February 2023, 103 (2) 63-76; DOI: https://doi.org/10.1124/molpharm.122.000591
  • Protein Kinases and Cross-talk between Post-translational Modifications in the Regulation of Drug Transporters
    You have access
    Protein Kinases and Cross-talk between Post-translational Modifications in the Regulation of Drug Transporters
    Xuyang Wang and Mei Hong
    Molecular Pharmacology January 2023, 103 (1) 9-20; DOI: https://doi.org/10.1124/molpharm.122.000604
  • You have access
    A Regional and Projection-Specific Role of RGSz1 in the Ventrolateral Periaqueductal Grey in the Modulation of Morphine Reward
    Farhana Sakloth, Omar B. Sanchez-Reyes, Anne Ruiz, Andrew Nicolais, Randal A. Serafini, Kerri D. Pryce, Feodora Bertherat, Angélica Torres-Berrío, Ivone Gomes, Lakshmi A. Devi, Daniel Wacker and Venetia Zachariou
    Molecular Pharmacology January 2023, 103 (1) 1-8; DOI: https://doi.org/10.1124/molpharm.122.000528
  • You have access
    Targeting Circuit Abnormalities in Neurodegenerative Disease
    Sharan Ram Srinivasan
    Molecular Pharmacology January 2023, 103 (1) 38-44; DOI: https://doi.org/10.1124/molpharm.122.000563
  • You have access
    Functional Assessment of Cancer-Linked Mutations in Sensitive Regions of Regulators of G Protein Signaling Predicted by Three-Dimensional Missense Tolerance Ratio Analysis
    Carolina Montañez-Miranda, Riley E. Perszyk, Nicholas H. Harbin, Jennifer Okalova, Suneela Ramineni, Stephen F. Traynelis and John R. Hepler
    Molecular Pharmacology January 2023, 103 (1) 21-37; DOI: https://doi.org/10.1124/molpharm.122.000614
  • You have access
    Transcriptional Regulation, Signaling Pathways, and Subcellular Localization of Corticotropin-Releasing Factor Receptors in the Central Nervous System
    Paula Amado, Juan Zegers, Hector E. Yarur and Katia Gysling
    Molecular Pharmacology December 2022, 102 (6) 280-287; DOI: https://doi.org/10.1124/molpharm.121.000476
  • You have access
    A Sentimental Segue
    Molecular Pharmacology December 2022, 102 (6) 288-289; DOI: https://doi.org/10.1124/molpharm.122.000632
  • You have access
    Announcement
    Molecular Pharmacology December 2022, 102 (6) 291; DOI: https://doi.org/10.1124/molpharm.122.000635

Pages

  • Previous
  • Next
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 1213
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics